Coffee Holding Co. Inc. (NASDAQ:JVA) has reported its results for the three months ending January 31, 2014 in which net income came in at $1.37 million or $0.22 per share compared to a net income of $937, 537 reported for the same period last year. The increase in net income was as a result of increased profitability in sales. Coffee Holding Co., Inc. (NASDAQ:JVA) shares after opening at $7.15 moved to $8.20 on last trade day and at the end of the day closed at $7.99. Company price to sales ratio in past twelve months was calculated as 0.38 and price to cash ratio as 12.73. Coffee Holding Co., Inc. (NASDAQ:JVA) showed a positive weekly performance of 26.83%.
Sibanye Gold Ltd (ADR) (NYSE:SBGL) is a South Africa gold producer. The company’s primary activities include extraction and processing of gold and its focus is on surface and underground gold mining projects. The company was spun out of Gold Fields as the gold major sought to dislodge itself from the labor issues in the South Africa mining industry. Sibanye Gold Ltd (ADR) (NYSE:SBGL) shares fell -0.82% in last trading session and ended the day on $9.68. SBGL return on equity ratio is recorded as -62.20% and its return on assets is 19.20%. Sibanye Gold Ltd (ADR) (NYSE:SBGL) yearly performance is 62.42%.
World Wrestling Entertainment, Inc (NYSE:WWE), an integrated media and entertainment company which develops, produce and markets television and pay-per-view event programming and live events and the licensing and sale of consumer products featuring its brands, is expected to announce a new cable TV home for its popular programs “Raw” and “Smackdown” by the end of this month. World Wrestling Entertainment, Inc. (NYSE:WWE) shares moved up 4.00% in last trading session and was closed at $30.94, while trading in range of $29.65-$31.11. World Wrestling Entertainment, Inc. (NYSE:WWE) year to date performance is 87.40%.
Chimerix Inc. (NASDAQ:CMRX)’s stock has been rising in the market by as much as 18.2% after the company received an approval from the FDA, for the use of one of its pill to try and save the life a 7 year old boy who is suffering from a viral infection. Chimerix Inc (NASDAQ:CMRX) weekly performance is 787%. On last trading day company shares ended up $57. Chimerix Inc. (NASDAQ:CMRX) distance from 50-day simple moving average (SMA50) is 757%. Analysts mean target price for the company is $89789.